What types of questions can be expected in a psychiatry board interview regarding pharmacotherapy and psychotherapeutic modalities?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Psychiatry Board Interview Questions: Pharmacotherapy and Psychotherapeutic Modalities

Expected Pharmacotherapy Questions

Board interviews will focus heavily on first-line medication selection, dosing strategies, and risk mitigation for common psychiatric disorders.

Medication Selection and Initiation

  • SSRIs are the cornerstone first-line pharmacotherapy for depression, anxiety disorders (including social anxiety disorder), and OCD, with sertraline and escitalopram preferred due to superior safety profiles 1
  • Expect questions about avoiding paroxetine and fluoxetine as first-line options due to higher adverse effect rates 1
  • For social anxiety disorder specifically, venlafaxine (SNRI) represents an equally valid first-line alternative to SSRIs 2, 1
  • OCD requires higher SSRI doses and longer trial durations (10-12 weeks) compared to other anxiety disorders before determining treatment failure 1
  • You must know that adequate medication trials require specific dose levels and duration - stimulants work quickly while antidepressants may require upward of 8 weeks 2

Risk Assessment and Monitoring

  • Be prepared to discuss suicidality risk with SSRIs in patients aged 18-29 years, requiring consideration of psychotherapeutic approaches first 2
  • Know the increased gastrointestinal bleeding risk with SSRIs in adults over 65, particularly when combined with NSAIDs or aspirin 2
  • Expect questions about metabolic monitoring with antipsychotics (olanzapine specifically requires monitoring for weight gain, diabetes risk, and dyslipidemia) 3
  • Benzodiazepines should be avoided for routine anxiety treatment due to addiction potential and risk of exacerbating opioid-induced respiratory depression 2, 1

Special Populations

  • Questions will address substance use disorder patients requiring increased monitoring frequency, consideration of naloxone provision, and consultation with addiction specialists when prescribing any controlled substances 2
  • Patients with comorbid depression and chronic pain should receive tricyclic or SNRI antidepressants for dual analgesic and antidepressant effects 2
  • Expect scenarios involving psychiatric medication in emergency settings, particularly acute agitation management and the need to rule out medical causes (delirium) before attributing symptoms to psychiatric illness 2

Expected Psychotherapy Questions

Interviews will test your knowledge of evidence-based psychotherapy modalities, their specific applications, and when to combine or choose them over pharmacotherapy.

CBT and Disorder-Specific Approaches

  • Individual CBT following the Clark and Wells model or Heimberg model is superior to group therapy for social anxiety disorder due to better clinical and cost-effectiveness 2, 1
  • Know that Exposure and Response Prevention (ERP) is the psychological treatment of choice for OCD, involving gradual exposure with instructions to abstain from compulsive behaviors 1
  • Patient adherence to between-session homework is the most robust predictor of good outcomes in CBT - this is a critical point for case discussions 1
  • Be prepared to discuss self-help with support based on CBT as an alternative when patients refuse face-to-face therapy 2

Psychodynamic and Combined Approaches

  • Understand that combining psychodynamic psychotherapy with medication may be superior for mood and anxiety disorders, though evidence involves mostly short-term therapy with small sample sizes 4
  • Psychotherapy benefits last longer after treatment ends compared to pharmacotherapy, offering better protection against relapse 5
  • Know that combination therapy (psychotherapy plus pharmacotherapy) is more effective than either alone in severe or chronic cases 5

Treatment Selection Algorithm

  • For social anxiety disorder, there is insufficient evidence to recommend combined treatment over monotherapy - you must choose based on patient preference and severity 2, 1
  • For OCD, beginning with CBT (especially ERP) or combined treatment is the best first option when expert psychotherapists are available 1
  • Expect questions about when psychotherapy alone is preferred: mild-to-moderate depression with good coping skills, patient preference, or concerns about medication side effects 2

Clinical Decision-Making Scenarios

Informed Consent and Shared Decision-Making

  • Be prepared to discuss detailed informed consent including common risks, patient-specific risks (e.g., weight gain risk in obese patients with family history of diabetes), and rare but serious events 2
  • Know how to address media controversies (suicidality with antidepressants, cardiac risks of stimulants) in consent discussions 2
  • Never minimize risks to enhance treatment acceptance - this harms the therapeutic relationship when adverse effects occur 2

Monitoring and Outcome Measurement

  • Use validated outcome measures regularly: LSAS or SPIN for social anxiety disorder, Y-BOCS for OCD 1
  • Expect questions about when to refer to specialists: marked treatment resistance, severe functional impairment, comorbid conditions complicating treatment, or self-harm risk 1
  • Know that treatment for depression can improve pain symptoms and might decrease overdose risk in patients with comorbid chronic pain 2

Emergency and Acute Settings

  • Medical stability assessment in psychiatric patients requires normal vital signs, noncontributory history/physical, and normal cognitive function before attributing symptoms purely to psychiatric causes 2
  • Be prepared to discuss pharmacologic treatment for acute agitation in emergency settings 2
  • Understand that elevated alcohol levels do not automatically preclude psychiatric evaluation in alert, cooperative patients with normal vitals 2

Common Pitfalls to Avoid

  • Never delay pharmacological treatment of suicidal patients due to concerns about manageable side effects - this represents inappropriate risk-benefit assessment 2
  • Don't rely on risk stratification tools (Opioid Risk Tool, SOAPP-R) to rule out risks - they show insufficient accuracy and you must exercise caution with all patients 2
  • Avoid prescribing opioids without optimizing treatment for comorbid depression and anxiety - untreated mental health conditions increase overdose risk 2
  • Don't assume trauma symptoms are purely psychiatric - always assess for medical causes using the FRAYED mnemonic (Frets/fears, Regulation difficulties, Attachment challenges, Yawning/yelling, Educational delays, Defeated/depressed/dissociated) 2

References

Guideline

Treatment for Social Anxiety Disorder and OCD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.